Umm Al-Qura University

Umm Al-Qura University

Pharmacogenomics test use in stroke from the perspective of Saudi healthcare professionals: The PharmGxSurvey

     From : - 2022/05/07 م , To : - 2025/05/29 م

Participant’s invitation letter
This is an invitation to complete a survey that aims to understand the healthcare providers views about analysing the barriers preventing pharmacogenomic (PGx) test use in patients with stroke or at risk for stroke and primary and secondary stroke care services. This research study is being conducted by a team of researchers at Umm A-Qura University. We feel that this is an important study and hope that you are interested in participating in this research. However, we have not passed on your personal details, and you do not have to take part. To find out more about taking part in the questionnaire, please read the information sheet or contact the research team Viahttps://uqu.edu.sa/hfazhari/App/Contact .The survey will take approximately 3-5 minutes to complete.
 
Participant’s invitation letter
This is an invitation to complete a survey that aims to understand the healthcare providers views about analysing the barriers preventing pharmacogenomic (PGx) test use in patients with stroke or at risk for stroke and primary and secondary stroke care services. This research study is being conducted by a team of researchers at Umm A-Qura University. We feel that this is an important study and hope that you are interested in participating in this research. However, we have not passed on your personal details, and you do not have to take part. To find out more about taking part in the questionnaire, please read the information sheet or contact the research team Viahttps://uqu.edu.sa/hfazhari/App/Contact .The survey will take approximately 3-5 minutes to complete.
 

    Study ethics Step 1 From 4

    * Have you read the information sheet for this study (Pharmacogenomics test use in stroke. Exploring healthcare professionals’ views)

    * . If yes, do you agree to take part in the survey and for us to use your anonymous answers?

    * . Please confirm that this questionnaire is being completed by the person to whom it was sent.

    Demographics Data Step 1 From 4

    * What is your sex?

    * What is your age?

    * What is your level degree of education?

     If you choose Other: (please specify)

    * What is your occupation?

     If you choose Other: (please specify)

    * What is your medical specialty?

     If you choose Other: (please specify)

    * Where is your primary hospital setting?

     If you choose Other: (please specify)

    * What is your primary practice setting?

     If you choose Other: (please specify)

    * What is your number of work experience?

    Pharmacogenomic (PGx) test knowledge Step 1 From 4

    * Do you know the pharmacogenomics (PGx) test?

    * After reading the information about the benefit of PGx test, do you think performing a PGx test can determine the optimal drug selection for patients?

    * Do you think performing a PGx test can determine the correct doses for patients?

    * Do you think performing a PGx test can decrease the number of drugs prescription for patients?

    * Do you think performing a PGx test can decrease the duration of drugs prescription for patients?

    * Do you think performing a PGx test assist in preventing adverse drug reactions for patients?

    * In your opinion, can PGx DNA detection save medical costs and lower the economic burdens for patients?

    * In your opinion, which of following factors could hinder the clinical application of PGx test in Sausi Arabia? (Please select all that apply)

     If you choose Other: (please specify)

    * In your opinion, which of the following can help in understanding PGx test, and be easier to apply to a specific drug?

     If you choose Other: (please specify)

    Experience and attitude Step 1 From 4

    * In your opinion, how important should the doctors know about PGx test?

    * In your opinion, which of the following can be dependent in determining drug doses?

     If you choose Other: (please specify)

    * In your opinion, which of the following may be a reason to request a PGx test?

     If you choose Other: (please specify)

    * In your opinion, which of the following may be a reason to refuse request a PGx test?

     If you choose Other: (please specify)

    * When treated patients with stroke or at risk for stroke, in your opinion which of the following drugs are associated with PGx assays? (Please select all that apply)

    * In your opinion, which of the following would you prefer to learn PGx in the future? (Please select all that apply)

     If you choose Other: (please specify)

     
    Loading